Anixa Biosciences Inc. Common Stock (ANIX)

About ANIX

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

www.anixa.com/

Fundamentals

Market cap

$116.70M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.30

Dividend yield

—

Beta

0.48

Avg. volume

—

Anixa Biosciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• ANIX

  Anixa Biosciences Inc. Common Stock

  $3.48

  ▼ 3.33%
  Market cap $116.70MP/E —
  $2.32$5.46
• BGM

  BGM Group Ltd. Class A Ordinary Shares

  $0.3251

  ▲ 11.34%
  Market cap $118.62MP/E —
  $0.2287$11.8
• GNLX

  Genelux Corporation Common Stock

  $2.66

  ▼ 7.64%
  Market cap $121.07MP/E —
  $2.29$8.54
• NRXP

  NRX Pharmaceuticals Inc. Common Stock

  $3.54

  ▼ 2.21%
  Market cap $111.95MP/E —
  $1.62$5.06
• PLYX

  Polaryx Therapeutics Inc. Common Stock

  $2.07

  ▼ 2.13%
  Market cap $110.66MP/E —
  $1.85$48.91
• IFRX

  InflaRx N.V. Common Stock

  $2.22

  ▼ 2.20%
  Market cap $124.34MP/E —
  $0.7984$2.95
• COYA

  Coya Therapeutics Inc. Common Stock

  $4.59

  ▼ 5.56%
  Market cap $107.43MP/E —
  $3.71$7.75

P/E shows — for peers not currently carrying a live signal of their own.

• Amit Kumar · July 31, 2026 · Buy

  5.0K @ $3.47
• Amit Kumar · July 27, 2026 · Buy

  5.0K @ $3.44
• Lewis H. Titterton Jr. · July 20, 2026 · Buy

  12.0K @ $3.47
• Amit Kumar · July 20, 2026 · Buy

  5.0K @ $3.46
• Lewis H. Titterton Jr. · July 15, 2026 · Buy

  2.8K @ $3.28
• Amit Kumar · July 10, 2026 · Buy

  5.0K @ $3.04
• Lewis H. Titterton Jr. · June 16, 2026 · Buy

  2.8K @ $2.64
• Amit Kumar · June 12, 2026 · Buy

  21.0K @ $2.5

Institutional Ownership

March 31, 2026

Total shares held

4.96M

Total value held

$12.50M

Institutional holders

59